about
Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq DataGenetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy.Ensemble-based classification approach for micro-RNA mining applied on diverse metagenomic sequencesIn silico identification of potential key regulatory factors in smoking-induced lung cancer.Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitorsIdentification of novel conserved functional motifs across most Influenza A viral strainsAn integrative meta-analysis of microRNAs in hepatocellular carcinoma.MysiRNA-designer: a workflow for efficient siRNA design.Correlating novel variable and conserved motifs in the Hemagglutinin protein with significant biological functions.Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span.MicroTarget: MicroRNA target gene prediction approach with application to breast cancer.Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA.New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.DeNovo: virus-host sequence-based protein-protein interaction prediction.Synthesis, pharmacological activity evaluation and molecular modeling of new polynuclear heterocyclic compounds containing benzimidazole derivatives.MicroRNA expression analysis in endometriotic serum treated mesenchymal stem cells.Accurate classification and hemagglutinin amino acid signatures for influenza A virus host-origin association and subtyping.Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.An integrated methodology for mining promiscuous proteins: a case study of an integrative bioinformatics approach for hepatitis C virus non-structural 5A protein.Natural genetic engineering of hepatitis C virus NS5A for immune system counterattack.The design of optimal therapeutic small interfering RNA molecules targeting diverse strains of influenza A virus.MysiRNA: improving siRNA efficacy prediction using a machine-learning model combining multi-tools and whole stacking energy (ΔG).Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients.Rational drug design for identifying novel multi-target inhibitors for hepatocellular carcinoma.MicroRNA-150 down Regulation in Acute Myeloid Leukaemia Patients and Its Prognostic ImplicationA review study: Computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseasesBioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinomaDown-regulation of circulating microRNA let-7a in Egyptian smokersEvaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicityWhole genome sequencing and bioinformatics analysis of two Egyptian genomes
P50
Q31143159-485B20EF-AEF6-4FE2-BC48-3230B3B0D01BQ33574642-EA6A4854-8032-47F9-9709-F22B58D05FACQ33732235-5605EBC2-23BF-4220-B6EC-EC4E2991F6F3Q33776567-64AB77FA-5B1D-4ECF-A792-B687A1A9C1DFQ34530512-3F73229C-1BA5-4083-8BEF-50C660F46766Q34564391-2D368D13-2707-4949-A87B-8E48D7A5806BQ35171752-3C3DE208-DB92-4D3C-9DE0-D02B3C85938AQ35455068-B6F66002-478A-4D90-8085-26B920C26124Q36908267-F7082639-5212-4A77-A025-2D2826FCC4C7Q38473905-81B4A109-3C28-40E6-B452-52CC03264CE6Q38759726-96129F87-7078-4A60-BB0E-85655E4E76D8Q38781527-8107735E-0393-452C-9F87-FF7D8F45D459Q38883800-DD5D45B9-5098-4F94-9461-5C0B7C065481Q38931027-181E8783-F34E-495D-8A50-65C31DB45915Q39221553-9367C241-3657-440D-81AA-98897F45C367Q41290520-B17A42C6-1D1A-4A38-BE20-64AA282ED59DQ42243624-7DD00CC6-9D0E-4B4E-BAB3-03F3F2CABECBQ42259303-42B04548-73C6-467D-BD77-916616A439D5Q42877650-4AC0557B-050E-48F8-BED5-EF70FB791D0DQ42991878-F139BFE0-CD03-49B0-99BB-17276D6867D8Q45362584-2289E939-65EF-46DC-9491-8F88B4EDFBB1Q45960812-2B5585C7-895E-4BC1-9D09-E46826A53E53Q53694954-068C3AAD-511C-4124-B6DF-956F2091C920Q54511228-6636F8A3-EFFE-4242-8066-04D99409F70EQ60053965-B95BDBF0-34E3-451A-9FD1-CE1755F95D3AQ62668412-CC975C6E-CC00-4052-A723-7956FEE09F18Q62668413-08964B22-7BB0-4919-81AE-5382F907EF05Q62668415-5D867482-127F-420A-9700-B6032B0826FCQ62668417-30D613DB-D56E-4D2F-9E94-FAD7934A1E51Q62668419-98D6F491-AED0-4186-A39C-BD66463D92C5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mahmoud ElHefnawi
@ast
Mahmoud ElHefnawi
@en
Mahmoud ElHefnawi
@es
Mahmoud ElHefnawi
@nl
type
label
Mahmoud ElHefnawi
@ast
Mahmoud ElHefnawi
@en
Mahmoud ElHefnawi
@es
Mahmoud ElHefnawi
@nl
prefLabel
Mahmoud ElHefnawi
@ast
Mahmoud ElHefnawi
@en
Mahmoud ElHefnawi
@es
Mahmoud ElHefnawi
@nl
P1153
P106
P1153
36113442800
56369149200
57076545300
P31
P496
0000-0003-3896-6911